How to Buy Resmed Stock
Resmed Inc
Resmed is a medical company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker RMD on the NYSE exchange.
Resmed stock last closed at $235.88, down 0.09% from the previous day, and has increased 28.6% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.34 percentage points. Resmed stock is currently +31.47% from its 52-week low of $179.42, and -10.33% from its 52-week high of $263.05.
As of Apr 25, 2025, there are 146.63M shares of RMD outstanding. The market cap of RMD is $34.59B. In the last 24 hours, 1.19M RMD shares were traded.
How to Buy Resmed Stock
Wondering how to invest in Resmed stock? Here's how.
- Decide where to buy Resmed stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you choose where to buy Resmed stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Choose your method of payment and add your details.
- Analyze Resmed stock: The Resmed ticker symbol is RMD. Is Resmed stock a good investment? Should you buy shares of RMD? How do RMD's underlying business fundamentals look? Do top analysts think Resmed is a good buy? Why has RMD's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if RMD is a good stock to buy).
- Execute your RMD buy order: Decide if you will purchase RMD shares at the current market price or use a limit order to buy RMD stock at a particular price.
- Get updates on your RMD investment: Create a watchlist to watch your position in Resmed stock.
Step 1: Decide where to buy Resmed stock
You need a brokerage account in order to access the NYSE market and buy RMD shares.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Technology to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've picked your brokerage, it's time to fill out some personal details so you can invest in RMD stock today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create a new brokerage account.
- Submit your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have filled out your info on stock apps to use, your next step is to transfer the money for your investment:
Check out this video walkthrough to see the process of transferring money into your brokerage account.
Step 4: Analyze Resmed stock
Once you have decided on the best place to buy Resmed stock, it's important to research their stock prior to investing, so you truly understand the risk and opportunity.
Resmed Numbers
RMD Due Diligence Score
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis in less time.
You can see all of the due diligence checks on RMD's stock page.
How is RMD stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge RMD's true value.
Using relative valuations measures:
- RMD may be undervalued based on its P/E ratio of 26.38x, relative to Medical Instruments & Supplies industry P/E ratio of 40.27x
- RMD may be overvalued based on its P/B ratio of 6.24x, relative to Medical Instruments & Supplies industry P/B ratio of 3.71x
- RMD may be overvalued based on its PEG ratio of 3.35x
You can access additional valuation analysis on RMD's stock here.
RMD Financial Health Summary
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the RMD balance sheet.
- RMD earnings of $1.58B is not sufficient to cover its interest payments.
- RMD profit margin has gone up from 20.9% to 26.2% in the past year.
- RMD has a low debt to equity ratio of 0.36.
- Total RMD debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the RMD balance sheet.
- RMD's operating cash flow of $1.65B allows it to safely service it's debt of $839.77M.
Is it a good time to buy Resmed stock, according to analysts?
Out of 7 Wall Street analysts who track RMD, the consensus analyst rating on Resmed is a Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Latest RMD Analyst Forecasts
Tim Rezvan, a bottom 4% analyst from KeyBanc maintains RMD with a strong buy rating and lowers their RMD price target from $280.00 to $269.00, on Apr 21, 2025.
Jonathan Block, a bottom 5% analyst from Stifel Nicolaus maintains RMD with a hold rating and lowers their RMD price target from $250.00 to $240.00, on Mar 5, 2025.
You can dig deeper into what analysts are saying on the Resmed stock forecast page.
RMD Technical Indicators
RMD Revenue
Last year, RMD earnings were $1.31B. During the last 5 year, RMD's earnings have gone up by 20.22% per year. This was slower than the Medical Instruments & Supplies industry average of 24.32%.
Last year, RMD revenue was $5.02B. In the last 5 year, RMD's revenue has grown by 11.67% per year. This was faster than the Medical Instruments & Supplies industry average of 9.16%.
Dig into RMD's earnings and revenue performance here.
Are RMD insiders buying or selling the stock?
Over the last year, insiders at RMD have sold more shares than they have bought.
Brett Sandercock, Chief Financial Officer of RMD, was the latest RMD insider to sell. They sold $215,580.00 worth of RMD stock on Apr 8, 2025.
Research more about who owns RMD stock here.
Does RMD stock generate passive income?
No, Resmed doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your RMD buy order
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a particular price, place a limit order.
Click the Open button and eToro will place your order.
If you want more help buying stocks on eToro, click the helpful video below:
Step 6: Get updates on your RMD investment
Now that you own some shares in RMD, you'll want to keep up with your company.
Put RMD on a watchlist to track the most important metrics related to your RMD stock.
RMD Feed
How to Buy Stock in Resmed
To summarize, here are the 6 steps for buying Resmed stock:
- Decide where to buy Resmed stock
- Open your brokerage account
- Deposit funds into your brokerage account
- Analyze Resmed stock
- Execute your RMD buy order
- Get updates on your RMD investment
If you are looking for a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep track of your investment in Resmed, create a watchlist on WallStreetZen today.
More Content You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.